Taiwan FDA registration 2398b9878f45edb3b366b4a61bec4857
FIA Biomed Precisa Blood Glucose Monitoring System
TW: 飛暘必析糖血糖檢測系統
Taiwan·Risk Class 2·MD·HMD BIOMEDICAL INC.·Registered Jun 22, 2017 – Jun 20, 2021CancelledRegistration details
- Analysis ID
- 2398b9878f45edb3b366b4a61bec4857
- License Form
- Ministry of Health Medical Device Manufacturing No. 005620
Company information
- Manufacturer
- HMD BIOMEDICAL INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- HMD BIOMEDICAL INC.
Product details
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jun 22, 2017
- Expiry Date
- Jun 20, 2021
- Cancellation Date
- Jan 26, 2022
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for FIA Biomed Precisa Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2398b9878f45edb3b366b4a61bec4857 and manufactured by HMD BIOMEDICAL INC.. The authorized representative in Taiwan is HMD BIOMEDICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices